Related by context. All words. (Click for frequent words.) 73 MAGE A3 ASCI 73 Tarceva TM 73 thetreatment 73 Afatinib 72 Degarelix 72 ZACTIMA 72 HuMax EGFr 72 Amrubicin 72 sorafenib tablets 71 CYT# potent vascular disrupting 71 catheter occlusion 71 RoACTEMRA 71 concurrent chemoradiation 71 kidney urologic 71 NB S# strontium malonate 71 gefitinib Iressa 71 metastatic colorectal 71 sorafenib Nexavar 71 YONDELIS 71 R sorafenib tablets 70 Cimzia TM 70 chronic thromboembolic pulmonary 70 Aplidin 70 fosbretabulin 70 ACTEMRA TM 70 PrevOnco ™ 70 depsipeptide 70 MGN# 70 Xanafide 70 metastatic neuroendocrine tumors 70 induced macular edema 70 docetaxel Taxotere ® 70 MGd 70 sargramostim 70 briakinumab 70 Peginterferon alfa 2b 70 Temsirolimus 70 Vidaza azacitidine 70 brivaracetam 70 TASKi3 70 Targretin capsules 70 Vascugel ® 70 Pemetrexed 70 Panzem R NCD 69 ADVEXIN therapy 69 liposomal doxorubicin 69 successfully commercialize Iluvien 69 LHRH receptor positive 69 Myocet 69 BrachySil TM 69 paclitaxel poliglumex 69 refractory prostate cancer 69 eribulin mesylate 69 neratinib 69 novel VDA molecule 69 metastatic malignant 69 NP2 Enkephalin 69 GORE TAG Device 69 CTAP# Capsules 69 Nexavar tablets 69 PI3K/Akt pathway inhibitor 69 generation purine nucleoside 69 Trofex 69 Xelox 69 liposomal formulation 69 UPLYSO 69 Dual Opioid 69 Silodosin 69 QuadraSphere 69 STRIDE PD 69 Allovectin 7 ® 69 cisplatin gemcitabine 69 Vascugel 69 GEM OS1 69 thalidomide Thalomid 69 metastatic pancreatic 69 Yondelis ® 69 fusion enhancers 69 histone deacetylase inhibitor 69 Evoltra ® 69 CIMZIA ™ 69 antiangiogenic therapy 69 novel oral anticoagulant 69 PROVENGE ® 69 BrachySil ™ 69 BEXXAR Therapeutic Regimen 69 RSD# oral 69 demonstrated antitumor activity 69 Zemplar Capsules 69 TEMODAL 69 standard chemotherapy regimen 69 vinca alkaloid 69 symptomatic paroxysmal AF 69 riociguat 69 multicenter Phase II 69 oral deforolimus 68 vernakalant hydrochloride 68 urothelial cancer 68 Trobalt 68 papillary renal cell carcinoma 68 HepaSphere 68 OZURDEX ® 68 acyclovir Lauriad R 68 Bayer HealthCare Onyx Pharmaceuticals 68 oral prodrug 68 recurrent glioblastoma multiforme 68 acadesine 68 TNF Tumor Necrosis Factor 68 non valvular atrial 68 terlipressin 68 BrachySil 68 histamine dihydrochloride 68 relapsed MM 68 Proxinium TM 68 mertansine 68 acetonide FA 68 Vicinium TM 68 CRMD# 68 GVAX Pancreas Vaccine 68 invasive candidiasis 68 zoledronate 68 HQK 68 EFAPROXYN 68 BENLYSTA ® 68 budesonide foam 68 Aflibercept 68 tolerability pharmacokinetics 68 Vandetanib 68 Onconase 68 GAMMAGARD 68 forodesine 68 glufosfamide 68 Ophena TM 68 clevidipine 68 ELACYT 68 fallopian tube cancers 68 Proellex TM 68 antiangiogenic agent 68 Allovectin 7 68 YONDELIS R 68 vapreotide acetate 68 INSPIRE Trial Phase III 68 hypervascular tumors 68 novel emulsion formulation 68 BRIM2 68 opioid induced bowel dysfunction 68 chemoradiotherapy 68 recurrent metastatic 68 Cx# [002] 68 rALLy clinical trial 68 biliary tract cancer 68 NAVISTAR R 68 phase IIIb 68 Capesaris 68 preclinical efficacy 68 Hepatocellular Carcinoma HCC 68 PROMUS Element Stent 68 sunitinib Sutent 68 Ceplene/IL-2 68 unresectable tumors 68 ZOLINZA 68 galiximab 68 Virulizin ® 68 ToGA 68 ospemifene 68 vidofludimus 68 esophageal candidiasis 68 CINQUIL 68 EGFR HER2 68 sunitinib malate 67 BCG refractory 67 Golimumab 67 bortezomib Velcade 67 xanthine oxidase inhibitor 67 GEM OS2 67 metastatic gastric 67 endocrine therapies 67 oral rivaroxaban 67 evaluating tivozanib 67 haematologic 67 multiple myeloma MM 67 Phase #b/#a clinical 67 selective estrogen receptor modulator 67 ACAPODENE 67 selective modulator 67 morphometric vertebral fractures 67 pharmacokinetic PK study 67 TNFerade TM 67 Clolar ® 67 NeuroSTAT ® 67 Phase IIIb clinical 67 Pertuzumab 67 relapsing remitting MS RRMS 67 G#DT 67 etanercept Enbrel 67 BR.# 67 liver resection surgeries 67 icatibant 67 recurrent NSCLC 67 esophagogastric 67 CBLC# 67 mTOR mammalian target 67 Surgical resection 67 Hsp# Inhibitor 67 metastatic GIST 67 Canvaxin TM 67 adult chronic ITP 67 EndoTAGTM 1 67 Insegia 67 Phase IIIb study 67 oral picoplatin 67 Noxafil 67 IMiDs ® compound 67 mRCC 67 fluoropyrimidine 67 inhaled iloprost 67 StemEx R 67 chimeric monoclonal antibody 67 anti angiogenic agents 67 sipuleucel T 67 OPAXIO 67 targeted radiotherapeutic 67 antiarrhythmic drug 67 pegylated liposomal doxorubicin 67 Sanofi Aventis Taxotere 67 novel histone deacetylase 67 Tasimelteon 67 HuLuc# 67 cilengitide 67 pharmacodynamic PD 67 CIMZIA TM 67 prospective multicentre 67 Helicobacter pylori eradication 67 radiolabeled TM# 67 NATRECOR ® 67 Squalamine 67 OvaRex ® MAb 67 metaglidasen 67 mTOR inhibitor 67 Catena ® 67 gemcitabine carboplatin 67 antibody MAb 67 CIMZIA TM certolizumab pegol 67 CINTREDEKIN BESUDOTOX 67 Glufosfamide 67 cannabinor 67 neoadjuvant treatment 67 Certican 67 platelet inhibitor 67 raloxifene Evista 67 zotarolimus 67 ixabepilone 67 inhaled AAT 67 Soliris eculizumab 67 Panzem R 67 humanised monoclonal antibody 67 teriflunomide 67 estramustine 67 TAXUS Element Paclitaxel Eluting 67 Augment Injectable 67 lexidronam injection 67 IRX 2 67 Platinol ® cisplatin 67 targeted antifolate 67 metastatic HRPC 67 Onrigin 67 oral ridaforolimus 67 erlotinib Tarceva 67 chemoembolization 67 eluting stent 67 pharmacodynamic properties 67 lapatinib Tykerb 67 Kepivance 67 PSMA ADC 67 Cellegesic 67 topical diclofenac 67 reslizumab 67 skeletal metastases 67 Plenaxis TM 67 FUSILEV enhances 67 phase Ib 67 gemcitabine Gemzar 67 refractory chronic lymphocytic 67 pharmacodynamic profiles 67 AZILECT ® 67 everolimus eluting stents 67 SIR Spheres 67 ThermoDox R 67 Combidex 67 refractory metastatic 67 pegylated alpha interferon 67 pancreatic prostate 66 cobiprostone 66 verteporfin 66 receptor tyrosine kinase inhibitor 66 Pyridorin 66 mTOR inhibition 66 PDX pralatrexate 66 GW# [003] 66 Archexin 66 liposome formulation 66 PHX# 66 keloid scarring 66 advanced hepatocellular carcinoma 66 Nexavar ® 66 radiotherapeutic 66 Pivotal Phase III 66 beta 1a 66 taxane refractory 66 lymphoid malignancies 66 Ophena 66 mycophenolate mofetil 66 Vectibix panitumumab 66 sitaxsentan 66 Phase IIb clinical trials 66 Prospective Randomized 66 edifoligide E2F Decoy 66 Mimpara 66 Meets Primary Endpoint 66 Plasmin 66 lintuzumab SGN 66 p# biomarker 66 diarrhea predominant irritable 66 Teysuno 66 JAK inhibitor 66 Halaven 66 Pirfenidone 66 Vimpat ® lacosamide 66 Gliadel Wafer 66 tubulin inhibitor 66 trastuzumab DM1 66 reduce serum phosphate 66 viral kinetics 66 anti arrhythmic drug 66 INTEGRILIN 66 CONBRIZA 66 oral FTY# 66 efaproxiral 66 RhuDex R 66 lenalidomide Revlimid 66 APTIVUS 66 epoetin alpha 66 Ixempra 66 hypoxia activated prodrug 66 GORE VIABAHN Endoprosthesis 66 Mipomersen 66 Cloretazine 66 Octreolin 66 R lenalidomide 66 ularitide 66 somatostatin analogue 66 ELIQUIS 66 percutaneous vertebroplasty 66 Neuradiab 66 pertuzumab 66 LibiGel ® 66 relapsing multiple sclerosis 66 Prostate AdenoCarcinoma Treatment 66 complement inhibitor eculizumab 66 Fibrin Pad 66 including eniluracil ADH 66 REMINYL ® 66 HDL Selective Delipidation 66 Entereg R 66 afamelanotide 66 BCIRG 66 LymphoStat B TM 66 cediranib 66 gemcitabine Gemzar ® 66 Oral NKTR 66 Phase 1b clinical trials 66 KIACTA ™ 66 Warfarin Coumadin 66 Doxil ® 66 XIENCE V PROMUS Stent 66 Intravitreal 66 interferon gamma 1b 66 thymalfasin 66 GATTEX ® 66 Olmesartan 66 follicular lymphoma FL 66 anastrazole 66 SPRYCEL ® 66 chemoradiation therapy 66 Edwards SAPIEN valve 66 analgesic efficacy 66 custirsen 66 orally inhaled 66 Hexvix ® 66 Eculizumab 66 intracavitary 66 pan HDAC inhibitor 66 AA Amyloidosis 66 Sebivo 66 retinal vein occlusion induced 66 PROCHYMAL 66 Epirubicin 66 TLK# 66 orally inhaled migraine 66 Aryplase 66 Prosaptide 66 taxane resistant 66 GOUT 66 Dabigatran etexilate 66 PEGylated interferon 66 Interferon beta 66 Lubiprostone 66 Zarnestra 66 Ranolazine 66 rhIGF-I/rhIGFBP-3 66 AVASTIN 66 Aviptadil 66 infusional 66 carotid artery stenting 66 Leukine ® 66 Zenvia ™ 66 constipation OIC 66 ALGRX 66 IL# PE#QQR 66 volociximab 66 Azedra 66 liver resection 66 ALA PDT 66 Alequel 66 somatostatin analog 66 LEUKINE 66 refractory ovarian cancer 66 cinacalcet 66 GLIADEL R Wafer 66 dual endothelin receptor antagonist 66 plus gemcitabine 66 OvaRex R 66 Initiate Clinical Trial 66 INTEGRILIN R eptifibatide Injection 66 Fibrillex TM 66 relapsed ovarian cancer 66 evaluating REVLIMID 66 Certolizumab pegol 66 Sudhir Agrawal D.Phil 66 patients undergoing percutaneous 66 RSR# 66 PRESEPT study 66 Ceflatonin 66 reteplase 66 aromatase inhibitor AI 66 CoFactor 66 ® natalizumab 66 Kamada AAT 66 Vernakalant 66 Glypromate 66 orBec 66 Dacogen injection 66 Pruvel 66 idursulfase 66 phase IIb study 66 Intravitreal injections 66 Inhaled nitric oxide 66 hoFH 66 Immunotherapeutic 66 immunotherapeutic vaccine 66 Tasigna prolongs 66 systemic immunosuppressive drugs 66 humanised antibody 66 Diamondback #deg 66 malignant ascites 66 OHR/AVR# 66 SinuNase TM 66 prostate carcinoma 66 Lenalidomide 66 adecatumumab 66 pharmacokinetic PK profile 66 neovascular age 66 SNT MC# 66 bevacizumab Avastin ® 66 dasatinib Sprycel 66 Fludara ® 66 Personalized Immunotherapy 66 prokinetic agent 65 gallium nitrate 65 mitoxantrone plus 65 topically administered 65 Amgen denosumab 65 samalizumab 65 Androxal TM 65 ONCASPAR 65 Apoptone 65 R roscovitine 65 Dasatinib 65 postoperative chemotherapy 65 drug zotarolimus 65 Dacogen decitabine 65 demonstrated clinically meaningful 65 AEG# 65 Trandolapril 65 KRAS status 65 Myocardial Perfusion Imaging 65 OMAPRO ™ 65 monoclonal anti 65 pharmacokinetic equivalence 65 symptomatic VTE 65 toenail onychomycosis 65 Vascugel R 65 liposomal amphotericin B 65 recurrent malignant glioma 65 NovoTTF #A 65 PrevOnco 65 inhibitor RG# 65 vemurafenib 65 refractory colorectal cancer 65 XGEVA 65 Pivotal Trial 65 intravesical infusion therapy 65 TELINTRA 65 ViaDerm hPTH #-# 65 nab paclitaxel 65 PLX STROKE targeting 65 EP #R 65 goserelin 65 Urocidin 65 Antisoma AS# 65 eprotirome 65 nonmetastatic prostate cancer 65 PD LID 65 KRAS mutations occur 65 #I TM# 65 pretransplant 65 prospective multicenter study 65 denileukin diftitox 65 investigational antiplatelet agent 65 CTEPH 65 plus COPEGUS 65 Zybrestat 65 BCR ABL inhibitor 65 allogeneic HSCT 65 alefacept 65 Traficet EN 65 Akt activation 65 Teriflunomide 65 Pharmacokinetic studies 65 paclitaxel eluting stents 65 Allovectin 7 R 65 systemic anaplastic large 65 micafungin 65 CLARITY study 65 palifermin 65 AzaSite Plus 65 HuMax 65 vismodegib 65 GP IIb IIIa inhibitors 65 TH# [003] 65 Irinotecan 65 Taxotere chemotherapy 65 EOquin TM 65 erlotinib Tarceva ® 65 dyslipidemia hypertension diabetes 65 tanespimycin 65 prostate carcinomas 65 gemcitabine chemotherapy 65 prognostic variables 65 eritoran 65 Teriparatide 65 Achieves Primary Endpoint 65 lucinactant 65 drug eluting stent DES 65 secondary hyperparathyroidism 65 histological subtype 65 IMiDs ® 65 delivers fluocinolone acetonide FA 65 Safinamide 65 Arranon 65 aspirin clopidogrel 65 trabectedin 65 LymphoStat B belimumab 65 metastatic CRC 65 vinorelbine tartrate 65 investigational immunotherapy 65 enzastaurin 65 CLL SLL 65 6R BH4 65 alvespimycin 65 ruxolitinib 65 metastatic lymph nodes 65 IONSYS TM 65 IMiDs R 65 ritonavir boosted 65 RhuDex ® 65 indibulin 65 Tekamlo 65 visilizumab 65 Procoralan 65 ZYBRESTAT fosbretabulin 65 Orally administered 65 chronic idiopathic thrombocytopenic purpura 65 dalteparin 65 AZX# 65 Orphan Drug status 65 pemetrexed Alimta 65 axitinib 65 palliative radiotherapy 65 certolizumab 65 Tectin TM 65 treat chronic sinusitis 65 Dalbavancin 65 Tavocept 65 Fodosine 65 Fondaparinux 65 OZURDEX 65 SANVAR 65 antiresorptive 65 dirucotide MBP# 65 vascular disrupting agents 65 diagnostic biomarker 65 SCH # 65 Eli Lilly Cymbalta 65 tecarfarin 65 Prestara 65 gastrointestinal stromal tumors GIST 65 methylnaltrexone bromide 65 Xcytrin R 65 Aclidinium 65 myelodysplastic myeloproliferative diseases 65 oral talactoferrin 65 fulvestrant 65 paclitaxel Taxol R 65 gadobutrol 65 non nucleoside 65 Actimmune ® 65 amrubicin 65 Bezielle 65 non metastatic osteosarcoma 65 microtubule inhibitor 65 NV1FGF 65 MYDICAR 65 Raptiva R 65 assessing T DM1 65 Thalomid ® 65 pediatric acute lymphoblastic 65 TM Drug Eluting 65 CytoSorb TM 65 Phase Ib II 65 Pivotal Clinical Trial 65 Advagraf 65 rotigotine transdermal patch 65 huC# DM4 65 lung pancreatic 65 transarterial 65 rituximab Rituxan 65 TO AVOID PREGNANCY WHILE 65 5 Fluorouracil 65 phase IIb trial 65 immune modulating 65 migalastat HCl 65 IRESSA 65 deferiprone 65 prostate cancer PCa 65 endothelin antagonist 65 lenalidomide dexamethasone 65 Initiates Enrollment 65 Raptiva ® 65 tramiprosate Alzhemed TM 65 Vascular Wrap TM 65 Angiox ® 65 Carotid endarterectomy 65 trastuzumab DM1 T DM1 65 hyaluronidase enzyme 65 docetaxel Taxotere R 65 biologic DMARD 65 Xeloda ® 65 non resectable metastatic 65 PhG alpha 1 65 SUTENT ® 65 EDEMA3 65 RE LY ® 65 lenalidomide Revlimid R 65 direct thrombin inhibitors 65 SYNERGY Stent 65 multicenter randomized controlled 65 Perforomist ™ Inhalation Solution 65 Solazed 65 LungAlert TM 65 trastuzumab emtansine T DM1 65 Hodgkin lymphoma HL 65 PEGINTRON TM 65 durable pain palliation 65 DEEP AF 65 oxaliplatin Eloxatin 65 DAVANAT 65 Factor VIIa 65 rheumatoid arthritis psoriatic arthritis 65 Anturol TM 65 ExTRACT TIMI 65 HepDirect prodrug 65 azilsartan medoxomil 65 SinuNase ™ 65 alkylating agent 65 MTP inhibitor 65 Carotid Revascularization Endarterectomy vs. 65 EchoCRT 65 BEMA TM Fentanyl 65 DexaSite 65 colesevelam HCl 65 Removab 65 pregabalin Lyrica 65 ibandronate 65 Benlysta belimumab 65 ORENCIA R 65 Retisert TM 65 schizophrenia CIAS 65 Phase 1a clinical 65 benign prostatic hypertrophy BPH 65 prulifloxacin 65 gemcitabine cisplatin 65 antitumor effect 65 NovoTTF 65 preclinically 65 aflibercept 65 fallopian tube carcinoma 65 Saforis 65 Rasagiline 65 TBC# 65 efficacy tolerability 65 pancreatic enzyme replacement 65 romidepsin 65 CHOP chemotherapy 65 prucalopride 65 Vidaza ® 65 CA9 SCAN 65 luteinizing hormone releasing 65 lymphomas leukemias 65 XP# XP# 65 farletuzumab 65 cinacalcet HCl 65 radiochemotherapy 65 BRILINTA 65 Neulasta R 65 murine model 65 chemotherapeutic regimen 65 LUX Lung 65 Camptosar ® 65 Hormone Refractory Prostate Cancer 65 GnRH agonist 65 interferon ribavirin 65 myocardial necrosis 65 nodal metastasis 65 LHRH antagonists 65 Torisel 65 Evoltra 65 sodium thiosulfate STS 65 pamidronate 65 Alocrest 65 lasofoxifene 65 rNAPc2 65 prospective multicenter 65 Gefitinib 65 transurethral 65 regorafenib 65 Egrifta 65 Qutenza TM 65 placebo controlled clinical 65 PRECISE 65 EGS# 65 investigational monoclonal antibody 65 R sipuleucel T 65 adalimumab Humira 65 aromatase inhibitors AIs 65 prospectively defined 65 Q#IR 65 Inhalation Solution 65 oral Janus kinase 65 octreotide implant 65 mTOR inhibitors 65 Hycamtin ® 65 Coronary Artery Bypass Graft 65 drotrecogin alfa activated 65 huN# DM1 65 hyperphenylalaninemia HPA due 65 Anti Bacterial Envelope 65 hypereosinophilic syndrome 65 refractory angina 65 LAB CGRP 65 Eribulin 65 unresectable HCC 65 Cancidas 65 selective adenosine 65 Novartis Afinitor 65 DIFICID ™ 65 antiplatelet agent 65 herpetic keratitis 65 VAPRISOL 65 Muraglitazar 65 prospective randomized multicenter 64 thromboembolic disease 64 docetaxel chemotherapy 64 deCODE AF TM 64 EXPAREL TM 64 Mepact 64 DAPT 64 pancreatic adenocarcinoma 64 pouchitis 64 Roche Xeloda 64 plus prednisone 64 gastrointestinal stromal tumor GIST 64 Rheos System 64 PDE# inhibitors 64 GERD migraine headaches 64 oral antiviral 64 Quinamed 64 IMiDs 64 Exherin TM 64 FASLODEX 64 BAY #-# 64 MYLOTARG 64 Corlux 64 thorough QT 64 preclinical pharmacokinetic 64 adjuvant therapies 64 Glycopyrrolate 64 NMIBC 64 Faslodex 64 Ketotransdel 64 ARCOXIA 64 topoisomerase II inhibitor 64 potent antiproliferative 64 Brinavess 64 Gemzar ® 64 APTIVUS R 64 photocoagulation 64 CIPN 64 MORAb 64 urate lowering 64 Alequel ™ 64 CP CPPS 64 5 fluorouracil leucovorin 64 STARFlex R 64 Triapine R 64 hereditary deficiency 64 Nexavar sorafenib 64 HIF PH inhibitors 64 oxypurinol 64 Tesmilifene 64 Cypher Sirolimus 64 registrational Phase 64 FOLOTYN ® 64 Isolagen Therapy 64 Genasense ® 64 FOLFOX6 chemotherapy regimen 64 Levoleucovorin 64 deforolimus 64 multicenter Phase III 64 phase IIa clinical 64 IgG1 monoclonal antibody 64 Dyloject TM 64 HER2 positive metastatic breast 64 FRAGMIN 64 TYZEKA 64 Daclizumab 64 cMET 64 sapacitabine CYC# 64 somatostatin analogues 64 PREOS R 64 Panzem NCD 64 Velcade bortezomib 64 eltrombopag 64 severe gastroparesis 64 Resolute stent 64 LEVADEX ™ 64 urocortin 2 64 Drug Eluting Stent System 64 Navelbine ® 64 Bosutinib 64 Solazed TM 64 Accelerated Partial Breast Irradiation 64 aurora kinase 64 candidate TNFerade biologic 64 intra abdominal infections 64 Alimta pemetrexed 64 AAG geldanamycin analog 64 Cimzia ® certolizumab pegol 64 sirolimus eluting 64 Alvesco R 64 Chemophase 64 oral mTOR inhibitor 64 squamous non 64 metastatic colorectal carcinoma 64 monoclonal antibody conjugated 64 glucocorticoid induced osteoporosis 64 carotid artery stenting CAS 64 TAXUS TM 64 BCG refractory carcinoma 64 myelofibrosis polycythemia vera 64 grade cervical dysplasia 64 Lambert Eaton Myasthenic 64 alfa 2a 64 investigational humanized monoclonal antibody 64 paclitaxel Taxol 64 HoFH 64 cytoreductive nephrectomy 64 RezularTM 64 Tumor Response 64 Primary endpoints 64 deep venous thromboses 64 weekly subcutaneous injections 64 tumor necrosis 64 small molecule Hedgehog 64 Folfox 64 EVIZON 64 antiangiogenic agents 64 radiotherapy RT 64 peripheral artery 64 Subgroup analysis 64 RIGScan CR 64 nalbuphine ER 64 Angiox R 64 GTC recombinant human 64 CellCept mycophenolate mofetil 64 elacytarabine 64 superficial basal cell carcinoma 64 oxymorphone ER 64 ILUVIEN ® 64 UCB Keppra 64 Protelos R 64 MabCampath 64 bardoxolone methyl 64 Bayer Onyx 64 XYOTAX TM 64 alicaforsen enema 64 multicentre randomized 64 novel therapeutic antibodies 64 Elocalcitol 64 albiglutide 64 Tolvaptan 64 biologic therapy 64 alemtuzumab MS 64 uricase 64 V Everolimus Eluting Coronary 64 motesanib 64 genomic biomarker 64 Toremifene 64 Deforolimus 64 TAXUS Liberté stent 64 previously untreated follicular 64 Percutaneous Transluminal Coronary Angioplasty 64 Eraxis 64 Syncria R 64 interferon beta therapy 64 Microwave Ablation System 64 pediatric Crohn disease 64 Combination REOLYSIN R 64 plasma kallikrein inhibitor 64 lorvotuzumab mertansine 64 pediatric malignancies 64 Acute Ischemic Stroke 64 IV acetaminophen 64 dimeglumine 64 Preclinical studies suggest 64 β blockers 64 randomized multicenter trial 64 Prodarsan R 64 intensive lipid lowering 64 steroid refractory 64 RANK Ligand inhibitor 64 TM Everolimus Eluting 64 peritoneal carcinomatosis 64 Iluvien TM 64 GRNCM1 64 stent DES 64 Cleviprex TM clevidipine 64 IMA# 64 Sirolimus eluting Coronary Stent 64 oral diclofenac 64 Vidofludimus 64 deCODE ProstateCancer TM 64 Recurrent Glioblastoma 64 IIa trials 64 salmeterol fluticasone 64 FDG PET imaging 64 benign prostatic hyperplasia enlarged 64 Dupuytren Contracture 64 fully bioabsorbable 64 hormone refractory metastatic prostate 64 Troxatyl 64 relapsed ALL 64 gynecologic procedures 64 Cloretazine R 64 multicenter prospective 64 Zoraxel 64 TORISEL 64 Phase III ADT 64 RAPTIVA 64 isoform selective 64 acyclovir Lauriad ® 64 PEGylated anti 64 colorectal liver metastases 64 esophageal gastric 64 exemestane Aromasin 64 Carfilzomib 64 lanthanum carbonate 64 external beam radiotherapy 64 erythropoietic